StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · SIBN·Healthcare

SI-BONE, Inc. Stock Analysis & AI Score

SI-BONE, Inc. (SIBN) has an ST Score of 68.4 (B+), driven by its Momentum (A) and held back by its Forecast (B-). Analysts rate it Buy with a $23.00 price target (+12.0% upside).

Market Closed
$20.54
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
68
ST Score
68.4/100B+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of

AI Daily Briefing

Analysis by AI

SIBN Stock Price History

—

SIBN Technical Indicators

FMP

Earnings Surprises

Analyst Forecast

Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…

Analyst Price Target

ESG Score

SIBN Latest Stock News

ST Score

SIBN
68.4out of 100
Grade B+

SI-BONE, Inc. (SIBN) has an ST Score of 68.4 (B+), driven by its Momentum (A) and held back by its Forecast (B-). Analysts rate it Buy with a $23.00 price target (+12.0% upside).

Strongest
MomentumA
Weakest
ForecastB-
All factor grades
  • MomentumA
  • ProfitabilityA-
  • Financial StrengthB+
  • GrowthB+
  • ValuationB
  • ForecastB-
  • Piotroski5/9
Score methodology

Press Releases

Company Contact Details

SIBN stock: frequently asked questions

What is SIBN's ST Score?

SI-BONE, Inc. (SIBN) has an ST Score of 68.4 (B+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SIBN a buy, hold, or sell?

Analysts rate SIBN a Buy, with a price target of $23.00 (+12.0% vs the current price). Our ST Score grades it B+ (68.4/100). The ST Score is a data-driven signal, not a recommendation.

What are SIBN's factor grades?

Valuation B, Profitability A-, Financial Strength B+, Momentum A, Growth B+, Forecast B-.

What is SIBN's valuation grade?

SI-BONE, Inc. (SIBN) earns a valuation grade of B, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SIBN's growth grade?

SI-BONE, Inc. (SIBN) earns a growth grade of B+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SIBN's profitability grade?

SI-BONE, Inc. (SIBN) earns a profitability grade of A-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SIBN's financial strength grade?

SI-BONE, Inc. (SIBN) earns a financial strength grade of B+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for SIBN?

The average analyst price target for SI-BONE, Inc. (SIBN) is $23.00 from 10 analysts, which is +12.0% versus the recent price of $20.54.

What is SIBN's Piotroski score?

SI-BONE, Inc. (SIBN) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.